Full-Time

Clinical Specialist-Pittsburgh/Cleveland

Posted on 7/25/2024

ReCor Medical

ReCor Medical

51-200 employees

Develops ultrasound technology for hypertension treatment

Compensation Overview

$110k - $130kAnnually

Junior, Mid

Remote in USA

Category
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Required Skills
Sales
Communications
Requirements
  • Clinical experience in cardiovascular procedures or at least 2 years of clinical case support.
  • Bachelor’s degree
  • Open to travel up to 50% of the time to various locations
  • Able to travel overnight 1-2+ nights a week depending on regional needs.
  • Able to work 7:30am-5pm, with flexibility for early mornings, evenings and weekends based on regional needs.
  • Possesses strong administrative skills to ensure all necessary paperwork associated with cases or follow-up, or associated with data collection is correct.
  • Ability to quickly learn and understand technical information and teach it to others.
  • Strong interpersonal skills and a team player.
  • Ability to build relationships with key stakeholders.
  • Excellent analytical and communication skills, both written and oral.
Responsibilities
  • Represent ReCor Medical during cases to ensure customer and patient success with products and demonstrates expertise in troubleshooting techniques.
  • Fulfills the duties of a Cardiology Sales Executive in vacant territories and supports procedures as directed by the Commercial Team.
  • Assists CSE, as needed, when opening new accounts
  • Assists in product demonstration and troubleshooting at medical education events
  • Provide technical support when required for new product launches. This includes collection of data and support clinical sites.
  • Works to gather and share clinical feedback from the field to assist with product development and design review.
  • Works with the Quality department to help track device-related clinical feedback and complaints.
  • Educates and trains physicians and hospital personnel on technical matters related to our products by conducting and/or coordinating: One-on-one training sessions, In-service education programs, Seminars and/or outside symposium.
  • Collects and studies information about new and existing products and monitors competitor sales, prices, and products.
  • Provides clinical expertise/guidance to internal colleagues.
  • Serves as an effective ReCor Medical representative to physicians and supports staff regarding products.
  • Meets with existing and potential customers to identify their clinical needs, goals, and requirements.
  • Use consultative selling techniques to identify potential sales opportunities within the account.
  • Responds to customer needs and reports customer complaints regarding products and service by developing and/or working with other personnel.
  • Builds rapport with all pertinent account stakeholders, including physicians, nurses, technologists, and administrators.

ReCor Medical focuses on treating hypertension, a condition that affects over 1 billion people globally. The company has created the Paradise System, which utilizes non-focused ultrasound technology to perform renal denervation, a procedure that targets kidney nerves to help lower blood pressure. This system is particularly beneficial for patients who do not respond well to standard blood pressure medications. ReCor Medical is dedicated to clinical research and development, conducting trials like the RADIANCE Global Program to validate the safety and effectiveness of its technology. Unlike many competitors, ReCor Medical emphasizes rigorous clinical testing and aims to provide a new treatment option for hypertension. The company's goal is to improve the lives of patients with high blood pressure through innovative medical devices.

Company Size

51-200

Company Stage

Debt Financing

Total Funding

$29.2M

Headquarters

Palo Alto, California

Founded

2009

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA approval of the Paradise System opens new US market opportunities.
  • Global renal denervation market projected to grow at 35% CAGR until 2030.
  • Lara Barghout's appointment as CEO is expected to drive strategic growth.

What critics are saying

  • Competition from Medtronic could impact ReCor's market share.
  • Reliance on FDA approval means potential regulatory setbacks could delay market entry.
  • New CEO may lead to strategic shifts disrupting current operations.

What makes ReCor Medical unique

  • ReCor Medical's Paradise System uses non-focused ultrasound for renal denervation.
  • The system targets kidney nerves, crucial in regulating blood pressure.
  • ReCor's focus on non-pharmacological treatment offers an alternative to traditional medications.

Help us improve and share your feedback! Did you find this helpful?

Company News

PR Newswire
May 17th, 2024
Recor Medical Unterstützt Weltweite Aktionen Zum Welt-Hypertonie-Tag: Frühzeitige Intervention Und Kontinuierliche Innovation Sind Der Schlüssel Zur Bekämpfung Des Stillen Killers, Von Dem Milliarden Menschen Weltweit Betroffen Sind

FRANKFURT, GERMANY and PALO ALTO, Calif., 17. Mai 2024 /PRNewswire/ -- Bluthochdruck, auch Hypertonie genannt, betrifft einen von drei Europäern über 30 Jahre und mehr als eine Milliarde Menschen weltweit. Er wird auch als "stiller Killer" bezeichnet, weil viele Menschen nicht wissen, dass sie daran leiden, und er im Laufe der Zeit zu ernsthaften gesundheitlichen Problemen führen kann. Bluthochdruck ist weltweit der größte Verursacher von Krankheiten und wird mit einer um fünf Jahre verringerten Lebenserwartung in Verbindung gebracht. Er ist ein wichtiger Risikofaktor für Herzkrankheiten, Schlaganfälle, Herzinfarkte und andere schwerwiegende Gesundheitsprobleme.Bloodpressure Measurement is important with HypertensionDer 17. Mai ist der Welt-Hypertonie-Tag, eine weltweite Aktion, die auf die Wichtigkeit der Blutdruckkontrolle hinweist und über diese folgenschwere chronische Krankheit aufklärt

PR Newswire
May 17th, 2024
Recor Medical Soutient Des Actions Mondiales À L'Occasion De La Journée Mondiale De L'Hypertension : L'Intervention Précoce Et L'Innovation Continue Sont Les Clés De La Lutte Contre Ce Tueur Silencieux Qui Affecte Des Milliards De Personnes Dans Le Monde

FRANCFORT, ALLEMAGNE and PALO ALTO, Calif., 17 mai 2024 /PRNewswire/ -- L'hypertension artérielle, ou HTA, touche un Européen sur trois de plus de 30 ans et plus d'un milliard de personnes dans le monde. L'hypertension est appelée le "tueur silencieux" parce que de nombreuses personnes ne savent pas qu'elles en souffrent et qu'elle peut entraîner de graves problèmes de santé au fil du temps. L'hypertension est le premier facteur contribuant à la charge de morbidité mondiale et a été associée à une réduction de cinq ans de l'espérance de vie. Elle constitue un facteur de risque majeur pour les maladies cardiaques, les accidents vasculaires cérébraux, les crises cardiaques et d'autres problèmes de santé graves.Bloodpressure Measurement is important with HypertensionLe 17 mai est la Journée mondiale de l'hypertension, une action mondiale visant à souligner l'importance du contrôle de la tension artérielle et à sensibiliser à cette maladie chronique aux conséquences graves. Recor Medical - le pionnier du système Paradise™ Ultrasound Renal Denervation (uRDN), une technique médicale récemment approuvée par la FDA pour le traitement de l'hypertension artérielle - participe à cet appel en sensibilisant les gens à cette maladie et en encourageant davantage d'innovations et un accès équitable à une intervention précoce et à des solutions durables pour les patients qui souffrent de cette maladie chronique.Selon un rapport de l'Organisation mondiale de la santé, le nombre d'adultes souffrant d'hypertension a doublé entre 1990 et 2019, passant de 650 millions à 1,3 milliard. Le rapport indique également que seuls 54 % des adultes souffrant d'hypertension sont diagnostiqués et que seuls 42 % reçoivent un traitement

PR Newswire
May 17th, 2024
Recor Medical Champions Global Action On World Hypertension Day: Early Intervention And Continued Innovation Crucial In Tackling This Silent Killer Impacting Billions Worldwide

FRANKFURT, GERMANY and PALO ALTO, Calif. , May 17, 2024 /PRNewswire/ -- Hypertension, or high blood pressure, affects one in three Europeans over the age of 30 and more than one billion people worldwide. Hypertension is known as the "silent killer" because many people do not know they have it and, over time, it can lead to serious health issues. Hypertension is the number one contributor to the burden of human disease globally, has been associated with a five-year reduction in life expectancy and is a major risk factor for heart disease, stroke, heart attacks and other serious health problems.Bloodpressure Measurement is important with HypertensionMay 17 is World Hypertension Day, a global initiative to highlight the importance of monitoring blood pressure and provide education about this devastating chronic disease. Recor Medical – the pioneer of the Paradise™ Ultrasound Renal Denervation (uRDN) System, a recently FDA-approved medical device-based procedure to treat hypertension – is joining the fight by promoting awareness and encouraging continued innovation and equitable access to early intervention and sustainable solutions for patients suffering from this chronic disease.According to a report from the World Health Organization, the number of adults with hypertension doubled between 1990 and 2019 from 650 million to 1.3 billion. The report also states that only 54 percent of adults with hypertension are diagnosed and only 42 percent receive treatment

Meta Medical Solutions
Nov 13th, 2023
Recor Medical introduces Paradise uRDN system in US

Recor Medical introduces Paradise uRDN system in US.

MD+DI
Nov 8th, 2023
FDA Approves Renal Denervation for High Blood Pressure

Recor has been developing the Paradise renal denervation system for the treatment of hypertension since 2009.

INACTIVE